GARETATUG REZETECAN
UNII FD5J5RLD4E

Substance Identification & Data

This profile provides standardized clinical and technical data for Garetatug Rezetecan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FD5J5RLD4E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3023285-06-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
FD5J5RLD4E
CAS Registry Number
3023285-06-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GARETATUG REZETECAN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C181025
National Cancer Institute reference terminology for clinical and research data.
INN ID
13530
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Garetatug Rezetecan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GARETATUG REZETECAN

Common Names & Synonyms

GARETATUG REZETECAN [INN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN CLAUDIN-18 ISOFORM A2) (HUMAN-MUS MUSCULUS MONOCLONAL HRP00965 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL HRP00965 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)GLYCYLGLYCYL-L-PHENYLALANYL-N-(((1R)-1-CYCLOPROPYL-2-(((1S,9S)-9-ETHYL-5-FLUORO-2,3,9,10,13,15-HEXAHYDRO-9-HYDROXY-4-METHYL-10,13-DIOXO-1H,12H-BENZO(DE)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-1-YL)AMINO)-2-OXOETHOXY)METHYL)GLYCINAMIDE
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CLDN18 (CLAUDIN 18, CLAUDIN-18, SURFACTANT ASSOCIATED PROTEIN J, SFTPJ) ISOFORM 2), HUMANIZED MONOCLONAL ANTIBODY; CONJUGATED ON AN AVERAGE OF FOUR CYSTEINYL RESIDUES TO REZETECAN, COMPRISING A LINKER AND A CAMPTOTHECIN DERIVATIVE (EXATECAN)

Technical Codes

SHRA1904

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus